Nicholas is a Senior Research Analyst for Health Care at ClearBridge Investments. He joined ClearBridge in 2007 and has 23 years of investment industry experience.
Prior to joining ClearBridge, he was a Research Associate at Bear Stearns, covering pharmaceuticals. He was previously an Associate Consultant at Plan A Consulting and a Research Scientist at Kosan Biosciences, specializing in biological sciences.
Nicholas received a Ph.D. in chemistry from Stanford University and a B.A. in chemistry from Washington University in St. Louis.
Nicholas’s key ESG considerations for the health care sector include access to medicines; addressing unmet medical needs; governance (especially capital allocation and executive compensation); drug safety and efficacy; enabling research and products that improve health care outcomes; ethical sales and marketing practices.
Experience
- 23 years of investment industry experience
- Joined ClearBridge Investments in 2007
- Bear Stearns - Research Associate for Pharmaceuticals
- Plan A Consulting, Inc. - Associate Consultant
- Kosan Biosciences - Research Scientist, Biological Sciences
- Ph.D. in chemistry from Stanford University
- B.A. in chemistry from Washington University in St. Louis